AACI Tech Gold

Harnessing Technology

Introduced in 2024, the AACI Tech Gold membership provides a forum for AACI cancer centers and technology companies to exchange ideas and imagine new possibilities for enhancing oncology through technology. By building important relationships with AACI cancer centers, Tech Gold members have the potential to accelerate progress against cancer, benefiting patients and their families.

AACI is grateful for the support and commitment of the 2026 Tech Gold members.
 

One Platform, Every Study

Wednesday, October 14 | 2:00 pm ET

Featuring Advarra, Lilly, and The University of Texas MD Anderson Cancer Center on running sponsored trials, investigator-initiated trials, and multisite consortium studies through one Archer integration, plus a first look at Archer AI

The IgniteData Archer platform connects electronic health record data to any electronic data capture (EDC) platform, whether a study is industry-sponsored on Veeva or Medidata, or an investigator-initiated or multisite trial running on Advarra EDC.

In this AACI Tech Gold webinar, participants will hear directly from the partners making that possible. Speakers will share how IgniteData's EDC-agnostic approach gives institutions one workflow for every study, along with the current state of Archer's site network across National Cancer Institute (NCI)-Designated Cancer Centers and beyond. Advarra will discuss its broader partnership with IgniteData, followed by a case study from The University of Texas MD Anderson Cancer Center on a multisite study on Advarra EDC, activated on Archer with a Kidney Cancer Research Consortium member institution.

The webinar will also feature a sponsor perspective from Lilly on its partnership with IgniteData, including results seen to date and the vision ahead, such as expanding the data domains sent through Archer. The webinar will close with a first look at Archer AI, which will expand Archer's reach to unstructured source data.

Webinar speakers (in order of appearance): Laura Hilty, IgniteData; Katy Wile, Advarra; Albert Renteria, The University of Texas MD Anderson Cancer Center; Christopher Thompson, MSN, RN, Lilly; and Heather Clark, IgniteData